跳至主要内容
临床试验/CTRI/2026/01/100056
CTRI/2026/01/100056尚未招募2/3 期

Pharmacognostical and Clinical study evaluating the efficacy of Rudraksha seed (Elaeocarpus ganitrus Roxb) in the management of Essential Hypertension

Department of Dravyaguna Faculty of Ayurveda IMS BHU Varanasi Uttar Pradesh India1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2026年3月6日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
108
试验地点
1

研究概览

简要总结

108 participants will be selected having Stage 1 Essential hypertension. 54 participants will be given with Rudraksh seed powder 5gm OD and 54 participants will be given Ramipril 5mg OD. The difference in reduction in blood pressure will be statistically analysed.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients having Stage 1 Essential Hypertension as per 8th JNC criteria Patients who are willing to participate in the study Patients with no significant change in their therapy over last 4 weeks prior to entry into the study.

排除标准

  • Known case of secondary hypertension e.g. Thyrotoxicosis, Renal artery stenosis, Pheochromocytoma etc.
  • Known case of renal disease, Diabetes mellitus Known case of ventricular hypertrophy and coarctation of aorta.
  • Known case of portal hypertension Women who were pregnant or were in the postpartum period or lactating.
  • Any inflammatory conditions like RA, SLE, IBD, Ankylosing Spondylitis.
  • Chronic Alcoholic and Chronic smokers Patients suffering from the systemic or serious illness like Leukemia, Chronic Kidney diseases, cirrhosis of liver, myocardial infarction, malignancy etc.
  • Patient with evidence of any target organ damage.

研究者

发起方
Department of Dravyaguna Faculty of Ayurveda IMS BHU Varanasi Uttar Pradesh India
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Diksha Sharma

Institute of Medical Sciences, Banaras Hindu University

研究点 (1)

Loading locations...

相似试验